Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds
Posted:
New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer.
Healthcare is increasingly recognising that wellbeing extends beyond the treatment of illness. Alongside advances in medicine and digital health, there is growing appreciation for the role that everyday self-care plays in supporting physical health, emotional wellbeing and confidence.
From nutrition…
As healthcare systems continue to evolve, technology is playing an increasingly important role in improving patient outcomes, supporting healthcare professionals and creating more efficient models of care. From artificial intelligence and robotics to advanced medical devices and digital health solutions,…
Attendees
Sponsors and Exhibitors
Contact us